Just Doing Experiments? Well, Ones that May Have Life-Saving Potential
Smart insulin; what is that? It’s the type of insulin that Chandra Bhattacharya, Ph.D., has spent her Breakthrough T1D-funded postdoctoral fellowship—the time right after you receive your doctoral degree, but are not ready for primetime as an assistant professor, yet—to pursue. And she has a lot of shoes to fill. At the Massachusetts Institute of […]
Helping Kids Talk T1D with Peers: CDE Offers Expert Tips
Shaina Hatchell discussed her children’s book “Shia Learns about Insulin," and how it can help normalize conversations about T1D for kids.
DIY Summer Camp at Home
The coronavirus pandemic shuttered most camps for the summer. But with a little creativity, T1D families can enjoy a bit of the summer camp experience at home.
Breakthrough T1D and Tandem Diabetes Care Partner to Help Educate, Support the T1D Community
New, national partnership will use Breakthrough T1D’s community-facing platforms to highlight benefits of devices such as insulin pumps, continuous glucose monitors and novel treatment approaches.
A New Way to Take Charge of Severe Hypos
During a recent Breakthrough T1D Facebook Live event, Mary Beth McNerney of Xeris Pharmaceuticals and Christine Beebe, MS, RD and Diabetes Educator discussed a new way to take charge of severe hypoglycemia episodes (“severe hypos”).
Nation’s Largest Insurer Expands Insulin Pump Coverage
In a victory for Breakthrough T1D’s Coverage2Control Campaign, people with T1D now have more choice in how they manage their diabetes.
A Message to Our Community
Breakthrough T1D is making the following commitments internally and to the T1D community to deliver tangible results for Black Americans living with T1D.
Breakthrough T1D’s One Night: The Power of Us Is Unstoppable
One Night. One Community. One Purpose: to show the world the undeniable power of people living with T1D.
Tandem Control-IQ—Now Authorized For Children
Tandem Diabetes announced FDA clearance of an expanded pediatric indication for the Tandem t:slim X2™ insulin pump with Control-IQ™ technology in children ages six and older.
At ADA, Breakthrough T1D-Funded Research Takes Center Stage (featuring a “Happy Hour” with Dr. Aaron Kowalski)
At the American Diabetes Association’s Scientific Sessions, which was held virtually from June 12-16, scientists presented on some of the most important topics, from artificial pancreas trials to immune therapy trials to prevention trials, all with the same goal: ending type 1 diabetes (T1D) and improving lives until that day comes. Breakthrough T1D played the […]
